TELETA PHARMA HOLDINGS LIMITED

Company number 11719162 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£6,789,108

Balance sheet as at 2025-06-30

View full accounts →

What it does

Holding Company

The company's own description, from its latest filed accounts.

Overview

Company type
Private Limited Company
Incorporated
2018-12-10
Employees
3 (2025 accounts)
Registered office
Old Station Road, Loughton, Essex, United Kingdom, IG10 4PL
Postcode
IG10 4PL
Capital
2 GBP
Accounts category
Group
Charges
0 outstanding

Accounts

Last made up to
2025-06-30
Next due by
2027-03-31
Financial year end
30 June

Confirmation statement

Last statement dated
2025-12-09
Next due by
2026-12-23
View filing history →

Nature of business (SIC)

  • 64209 Activities of other holding companies not elsewhere classified

Officers 3 current · 1 resigned

Christian BARRY Director
Appointed 2019-04-25
Appointed 2019-04-25
Appointed 2018-12-10

View all officers and resignations →

Group structure 2 subsidiaries

From persons-with-significant-control filings on the public register.

Contact details

Website
teleta.co.uk

Teleta are a dedicated pharmaceutical supply company that provide quality aesthetic and cosmetic leading brands at competitive prices.

Among its peers

Top 5%

by shareholders' funds, of 377 similar companies in IG

Among the biggest employers among its local peers (3 staff).

Among the oldest 25% of its local peers, trading since 2018.

No.15 of the largest activities of other holding companies not elsewhere classified companies in Ilford →

588 companies are registered at this postcode →

Competitors Ilford

This company ranks 15 among activities of other holding companies not elsewhere classified in Ilford.

Full league table →

The class of 2018

61%

of the 7,928 companies in this sector incorporated in 2018 are still active today; 35% have since been dissolved.

A fact about the year, not a forecast for this company.